Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 04 04:00PM ET
0.5470
Dollar change
0.0000
Percentage change
0.00
%
Index- P/E- EPS (ttm)-0.90 Insider Own14.84% Shs Outstand12.71M Perf Week8.10%
Market Cap7.10M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float11.05M Perf Month-13.35%
Income-8.24M PEG- EPS next Q- Inst Own1.76% Short Float3.02% Perf Quarter-15.98%
Sales0.51M P/S13.92 EPS this Y- Inst Trans3.22% Short Ratio2.30 Perf Half Y-29.53%
Book/sh0.66 P/B0.83 EPS next Y- ROA-51.96% Short Interest0.33M Perf Year-62.28%
Cash/sh0.06 P/C8.45 EPS next 5Y- ROE-90.91% 52W Range0.41 - 2.45 Perf YTD-52.84%
Dividend Est.- P/FCF- EPS past 5Y12.78% ROI-96.97% 52W High-77.67% Beta0.74
Dividend TTM- Quick Ratio0.34 Sales past 5Y2003.75% Gross Margin66.82% 52W Low34.96% ATR (14)0.05
Dividend Ex-DateSep 16, 2013 Current Ratio0.34 EPS Y/Y TTM74.62% Oper. Margin-1242.22% RSI (14)48.61 Volatility5.82% 8.24%
Employees19 Debt/Eq0.33 Sales Y/Y TTM-31.04% Profit Margin-1616.97% Recom3.00 Target Price20.20
Option/ShortNo / Yes LT Debt/Eq0.02 EPS Q/Q98.17% Payout- Rel Volume0.00 Prev Close0.55
Sales Surprise- EPS Surprise- Sales Q/Q2350.74% Earnings- Avg Volume144.94K Price0.55
SMA202.87% SMA50-5.62% SMA200-35.43% Trades Volume0 Change0.00%
Nov-14-24 09:00AM
Oct-22-24 08:45AM
Aug-15-24 07:30AM
Jul-18-24 10:31AM
Jul-09-24 07:16AM
09:00AM Loading…
Jul-02-24 09:00AM
Jun-25-24 09:00AM
Jun-12-24 09:20AM
May-24-24 09:00AM
May-22-24 09:00AM
May-17-24 10:52PM
May-15-24 11:14AM
09:25AM
May-09-24 09:35AM
Apr-18-24 09:25AM
09:00AM Loading…
Apr-17-24 09:00AM
Apr-10-24 08:30AM
Mar-26-24 08:30AM
Mar-21-24 08:30AM
Mar-19-24 08:30AM
Mar-14-24 09:30AM
Feb-27-24 08:30AM
Feb-15-24 08:30AM
Feb-12-24 08:30AM
Feb-08-24 09:17AM
Jan-03-24 07:24AM
Dec-07-23 08:30AM
Dec-05-23 08:30AM
Nov-21-23 08:30AM
Nov-16-23 10:05AM
09:00AM Loading…
Nov-15-23 09:00AM
Oct-26-23 08:30AM
Oct-17-23 08:30AM
Oct-09-23 08:30AM
Aug-23-23 08:30AM
Aug-17-23 09:19AM
Aug-10-23 08:30AM
Aug-07-23 08:30AM
Aug-03-23 09:20AM
Aug-01-23 08:30AM
Jul-31-23 09:30AM
Jul-27-23 09:22AM
Jul-26-23 08:30AM
Jul-24-23 12:30PM
Jul-06-23 08:30AM
Jun-26-23 08:30AM
Jun-20-23 08:30AM
Jun-12-23 08:30AM
Jun-06-23 08:30AM
May-22-23 08:30AM
May-04-23 08:30AM
Apr-26-23 08:30AM
Apr-10-23 08:30AM
Apr-06-23 08:30AM
Mar-31-23 06:49PM
Mar-20-23 07:00AM
Mar-14-23 07:00AM
Feb-28-23 08:30AM
Feb-23-23 04:16PM
Feb-21-23 08:30AM
Jan-19-23 08:30AM
Jan-18-23 08:25AM
Jan-05-23 08:30AM
Dec-20-22 11:05AM
Nov-17-22 08:30AM
05:16AM
Nov-14-22 06:20PM
Nov-07-22 08:30AM
Nov-02-22 08:30AM
Oct-05-22 08:30AM
Sep-23-22 08:30AM
Sep-16-22 09:36AM
Sep-13-22 08:30AM
Sep-09-22 08:30AM
Aug-22-22 08:30AM
Aug-18-22 08:30AM
Aug-15-22 05:48PM
Aug-02-22 08:30AM
Jul-18-22 08:30AM
Jul-13-22 08:30AM
Jul-06-22 08:30AM
Jun-30-22 08:30AM
Jun-21-22 08:30AM
Jun-16-22 08:30AM
Jun-10-22 08:30AM
Jun-07-22 01:10PM
Jun-01-22 08:30AM
May-25-22 08:30AM
May-23-22 07:30AM
May-16-22 05:46PM
03:25PM
May-13-22 08:30AM
May-12-22 09:00AM
08:30AM
May-10-22 08:30AM
May-05-22 08:30AM
May-03-22 08:30AM
Apr-28-22 08:30AM
Apr-26-22 08:30AM
Mar-31-22 04:18PM
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.